6533b861fe1ef96bd12c58f3

RESEARCH PRODUCT

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.

Oliver PfaarLuciana Kase TannoAntonella MuraroM. BewickG.w. CanonicaPascal DemolyMohamed H. ShamjiCezmi A. AkdisT. ZuberbierDirceu SoléH.-j. MallingJ MullolAlain DidierGunter J. SturmB. SamolinskiClaus BachertG. PassalacquaCarmen VidalAndrew BushL. CoxStephen R. DurhamAnca-mirela ChiriacV. CardonaAna I. TabarM. T. VenturaP. DevillierG. Du ToitEva-maria VargaDavid PriceThomas B. CasaleP. Rodriguez Del RioBarbara BohleD. Larenas-linnemannAziz SheikhG. Di LorenzoMargitta WormR. RueffR. Van ReeSusanne HalkenDavide CaimmiAlessandro FiocchiJ. C. SisulF. De BlayPiotr KunaR. Gerth Van WijkM. MatricardiMoises A. CalderonLudger KlimekSergio BoniniR. M. GomezGabriela SentiG. K. ScaddingG. K. ScaddingPeter EngNikolaos G. PapadopoulosAdam T. FoxJean BousquetB. M. BiloElideanna PastorelloEdward F. KnolJörg Kleine-tebbeT. HaathelaLars JacobsenR. MoesgesAdnan CustovicAllan LinnebergPeter HellingsJ. Just

subject

Pulmonary and Respiratory MedicineGerontologyAllergen immunotherapymedicine.medical_specialtyAllergyAl·lèrgiaEIP on AHAAllergy[SDV]Life Sciences [q-bio]ImmunologyAlternative medicineImmunoteràpiaReview03 medical and health sciences0302 clinical medicinemedicineJournal ArticleImmunology and Allergy030212 general & internal medicineAsthmaAllergen immunotherapyRhinitisbusiness.industryPrecision medicinemedicine.diseaseAsthma3. Good healthIntegrated care[SDV] Life Sciences [q-bio]AgeingAIRWAYS ICPs030228 respiratory systemGeneral partnershipAction planImmunologyImmunotherapybusiness

description

Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing. ispartof: Clinical and Translational Allergy vol:6 issue:1 pages:41-47 ispartof: location:England status: published

yearjournalcountryeditionlanguage
2016-12-01
https://hdl.handle.net/20.500.12530/24347